These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14294360)

  • 41. The prevention of Rhesus haemolytic disease.
    Finn R; Clarke CA
    Bibl Haematol; 1968; 29():225-30. PubMed ID: 4178380
    [No Abstract]   [Full Text] [Related]  

  • 42. Non-rhesus (D) blood group isoimmunization in obstetrics.
    Beal RW
    Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
    [No Abstract]   [Full Text] [Related]  

  • 43. [Erythroblastosis fetalis with combined incompatibility within the Rhesus and ABO systems].
    LEBECH PE; THOMSEN B
    Ugeskr Laeger; 1962 Feb; 124():245-7. PubMed ID: 14463265
    [No Abstract]   [Full Text] [Related]  

  • 44. ABO and Rh incompatibility. I. Fetal and neonatal mortality aith ABO and Rh incompatibility. Some new interpretations.
    Cohen BH
    Am J Hum Genet; 1970 Jul; 22(4):412-40. PubMed ID: 4988275
    [No Abstract]   [Full Text] [Related]  

  • 45. Blood group distribution and ABO haemolytic disease of the newborn in Jamaica.
    Lindo-Haynes G
    Med Lab Sci; 1980 Jun; 37(3):263-6. PubMed ID: 6783806
    [No Abstract]   [Full Text] [Related]  

  • 46. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus].
    Nersisian VM
    Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140
    [No Abstract]   [Full Text] [Related]  

  • 47. Genetics in medicine: a review. Immunogenetics. Genetics of immunological deficiency states.
    Clarke CA; Evans DA; Harris R; McConnell RB; Woodrow JC
    Q J Med; 1968 Apr; 37(146):220-41. PubMed ID: 4968507
    [No Abstract]   [Full Text] [Related]  

  • 48. [Prevention of anti Rh immunization].
    Pinon F
    Sem Hop; 1969 Sep; 45(37):2328-33. PubMed ID: 4187740
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hemolytic disease of the newborn from the viewpoint of the pediatrician].
    Janovský M; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):485-8. PubMed ID: 4982153
    [No Abstract]   [Full Text] [Related]  

  • 50. [INFLUENCE OF THE ABO BLOOD GROUP SYSTEM ON THE OCCURRENCE OF HEMOLYTIC DISEASE OF THE NEWBORN CAUSED BY RH INCOMPATIBILITY].
    BOSSI E
    Helv Paediatr Acta; 1964 Jun; 19():34-41. PubMed ID: 14189841
    [No Abstract]   [Full Text] [Related]  

  • 51. EFFECT OF ABO INCOMPATIBILITY ON PREGNANCY-INDUCED RH ISOIMMUNIZATION.
    DONOHUE WL; WAKE EJ
    Can Med Assoc J; 1964 Jan; 90(1):1-5. PubMed ID: 14105011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AMNIOCENTESIS FOR PRENATAL DIAGNOSIS OF ERYTHROBLASTOSIS FETALIS.
    QUEENAN JT; ADAMS DW
    Obstet Gynecol; 1965 Mar; 25():302-7. PubMed ID: 14268009
    [No Abstract]   [Full Text] [Related]  

  • 53. [Incidence of materno-fetal isoimmunization against the Rh factor (D)].
    Marmorino C
    Minerva Med; 1972 Dec; 63(86):4699-707. PubMed ID: 4629911
    [No Abstract]   [Full Text] [Related]  

  • 54. Rhesus and ABO incompatibility.
    Macnamara BG
    Br Med J; 1969 Mar; 1(5647):844. PubMed ID: 4975331
    [No Abstract]   [Full Text] [Related]  

  • 55. [Development and present status of immunoprophylaxis of Rh-sensitization].
    Radzuweit H
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1181-5. PubMed ID: 4994101
    [No Abstract]   [Full Text] [Related]  

  • 56. [ABSENCE OF THE ANEMIC-HEMOLYTIC SYNDROME IN THE CHARACTERISTIC CONDITIONS FOR HEMOLYTIC DISEASE OF THE NEWBORN].
    ANTONELLI G; VACCARO R
    Minerva Pediatr; 1963 Nov; 15():1252-4. PubMed ID: 14108682
    [No Abstract]   [Full Text] [Related]  

  • 57. [DIAGNOSIS, SEROLOGIC PROGNOSIS AND THERAPY OF FETO-MATERNAL IMMUNIZATION].
    ANDRE A
    Rev Med Liege; 1963 Oct; 18():641-5. PubMed ID: 14097934
    [No Abstract]   [Full Text] [Related]  

  • 58. HL-A antibodies and some immunological problems of pregnancy.
    Imre G; Keserü TL; Maráz A; Hetyei P
    Folia Biol (Praha); 1971; 17(6):414-7. PubMed ID: 5002841
    [No Abstract]   [Full Text] [Related]  

  • 59. [Current value of the Kleihauer test apropos of the prevention of fetomaternal isoimmunization].
    Carrière M; Battaglini PF; Nublat M; Serment H
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):69-76. PubMed ID: 4989262
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of discriminant analysis in relating maternal anti-D levels to the severity of haemolytic disease of the Newborn.
    Morley G; Gibson M; Eltringham D
    Vox Sang; 1977; 32(2):90-8. PubMed ID: 403679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.